Victory Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-26,441
Closed -$878K 2748
2022
Q4
$878K Sell
26,441
-17,526
-40% -$582K ﹤0.01% 1802
2022
Q3
$1.39M Sell
43,967
-108,816
-71% -$3.43M ﹤0.01% 1588
2022
Q2
$4.65M Sell
152,783
-6,243
-4% -$190K 0.01% 1265
2022
Q1
$4.11M Buy
159,026
+4,395
+3% +$114K ﹤0.01% 1325
2021
Q4
$3.15M Buy
154,631
+25,640
+20% +$523K ﹤0.01% 1427
2021
Q3
$2.48M Buy
128,991
+1,949
+2% +$37.5K ﹤0.01% 1534
2021
Q2
$2.82M Sell
127,042
-3,893
-3% -$86.3K ﹤0.01% 1532
2021
Q1
$3.44M Buy
130,935
+81,450
+165% +$2.14M ﹤0.01% 1473
2020
Q4
$925K Sell
49,485
-5,151
-9% -$96.3K ﹤0.01% 1820
2020
Q3
$928K Sell
54,636
-79,116
-59% -$1.34M ﹤0.01% 1737
2020
Q2
$3.12M Sell
133,752
-186,918
-58% -$4.35M ﹤0.01% 1296
2020
Q1
$2.69M Buy
320,670
+151,014
+89% +$1.27M ﹤0.01% 1478
2019
Q4
$1.66M Buy
169,656
+27,737
+20% +$271K ﹤0.01% 1578
2019
Q3
$1.35M Buy
141,919
+81,095
+133% +$770K ﹤0.01% 1614
2019
Q2
$723K Sell
60,824
-4,756
-7% -$56.5K ﹤0.01% 1345
2019
Q1
$1.16M Sell
65,580
-33,054
-34% -$582K ﹤0.01% 1222
2018
Q4
$1.71M Buy
98,634
+8,235
+9% +$143K ﹤0.01% 1073
2018
Q3
$1.35M Buy
90,399
+35,399
+64% +$527K ﹤0.01% 1206
2018
Q2
$875K Buy
55,000
+1,085
+2% +$17.3K ﹤0.01% 1284
2018
Q1
$766K Buy
53,915
+21,175
+65% +$301K ﹤0.01% 1291
2017
Q4
$458K Buy
32,740
+1,987
+6% +$27.8K ﹤0.01% 1336
2017
Q3
$440K Sell
30,753
-2,967
-9% -$42.5K ﹤0.01% 1342
2017
Q2
$531K Buy
33,720
+2,520
+8% +$39.7K ﹤0.01% 1301
2017
Q1
$431K Buy
31,200
+5,844
+23% +$80.7K ﹤0.01% 1337
2016
Q4
$449K Sell
25,356
-1,732
-6% -$30.7K ﹤0.01% 1285
2016
Q3
$523K Buy
27,088
+4,294
+19% +$82.9K ﹤0.01% 1239
2016
Q2
$444K Buy
22,794
+3,409
+18% +$66.4K ﹤0.01% 1069
2016
Q1
$400K Sell
19,385
-4,266
-18% -$88K ﹤0.01% 1082
2015
Q4
$485K Buy
23,651
+8,450
+56% +$173K ﹤0.01% 1041
2015
Q3
$260K Buy
15,201
+3,734
+33% +$63.9K ﹤0.01% 1084
2015
Q2
$213K Buy
+11,467
New +$213K ﹤0.01% 1103